CEACAM5 and neoplasm: When a meta-analysis of all the repeated hexatherapy studies for MC38-CEA was performed, it revealed that a combination of two components of the hexatherapy regimen may be sufficient to allow a tumor growth control (tumors that are smaller than 300 mm3) in a high percentage of mice (56%) (figure 2H).